Covington Investment Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-6,298
Closed -$1.32M 92
2016
Q4
$1.32M Sell
6,298
-380
-6% -$78.7K 0.56% 68
2016
Q3
$1.54M Sell
6,678
-220
-3% -$53.8K 0.7% 65
2016
Q2
$1.59M Buy
6,898
+630
+10% +$145K 0.7% 63
2016
Q1
$1.68M Buy
6,268
+415
+7% +$119K 0.76% 63
2015
Q4
$1.83M Sell
5,853
-59
-1% -$17.6K 0.85% 57
2015
Q3
$1.61M Buy
5,912
+27
+0.5% +$8.29K 0.85% 59
2015
Q2
$1.79M Sell
5,885
-27
-0.5% -$8.05K 1.12% 48
2015
Q1
$1.76M Buy
+5,912
New +$1.69M 1.22% 42

Other funds holding AGN

Covington Investment Advisors's AGN Position: Q1 2017 in Review

Covington Investment Advisors sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 6,298 shares — an estimated $1.32M sold.

Covington Investment Advisors first reported a position in AGN in Q1 2015 and held it in 8 quarters. The position peaked at $1.83M in Q4 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Covington Investment Advisors reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Covington Investment Advisors sold 6,298 Allergan plc shares in Q1 2017, an estimated $1.32M.
  • Covington Investment Advisors first reported a position in Allergan plc in Q1 2015 and held it in 8 quarters.
  • Covington Investment Advisors's Allergan plc position peaked at $1.83M in Q4 2015.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Covington Investment Advisors's 13F filing for Q1 2017, filed 11 May 2017.